F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 46.7 SEK -2.91% Market Closed
Market Cap: 636.1m SEK

EV/OCF
Enterprise Value to OCF

-12
Current
-13.8
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-12
=
Enterprise Value
605m SEK
/
Operating Cash Flow
-32.8m DKK
Market Cap EV/OCF
DK
Fluoguide AS
STO:FLUO
636.1m SEK -12
FR
Pharnext SCA
OTC:PNEXF
6T USD -242 135.3
US
Abbvie Inc
NYSE:ABBV
309.5B USD 21.9
US
Amgen Inc
NASDAQ:AMGN
140.9B USD 26
US
Gilead Sciences Inc
NASDAQ:GILD
112B USD 10.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.6B USD -116.1
US
Epizyme Inc
F:EPE
94.1B EUR -465
AU
CSL Ltd
ASX:CSL
137.8B AUD 34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.7B USD 16.4
US
Seagen Inc
F:SGT
39.3B EUR -72.7
NL
argenx SE
XBRU:ARGX
38.5B EUR -140.9
 
DK
F
Fluoguide AS
STO:FLUO
Average EV/OCF: 21.8
Negative Multiple: -12
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -242 135.3
US
Abbvie Inc
NYSE:ABBV
21.9
US
Amgen Inc
NASDAQ:AMGN
26
US
Gilead Sciences Inc
NASDAQ:GILD
10.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -116.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -465
AU
CSL Ltd
ASX:CSL
34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -72.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -140.9

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A